.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Check market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Procainamide hydrochloride - Generic Drug Details

« Back to Dashboard
Procainamide hydrochloride is the generic ingredient in seven branded drugs marketed by Parke Davis, Watson Labs, Ivax Sub Teva Pharms, Parkedale, Ani Pharms Inc, Abraxis Pharm, Idt Australia Ltd, Pharmafair, Warner Chilcott, West-ward Pharms Int, Eurohlth Intl Sarl, Smith And Nephew, Solopak, Apothecon, Intl Medication, Hospira, Inwood Labs, Ascot, Lederle, Vangard, King Pharms, Panray, Sandoz, Roxane, and Lannett, and is included in seventy-three NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for procainamide hydrochloride. Four suppliers are listed for this compound.

Summary for Generic Name: procainamide hydrochloride

Tradenames:7
Patents:0
Applicants:25
NDAs:73
Drug Master File Entries: see list8
Suppliers / Packagers: see list4
Bulk Api Vendors: see list55
Clinical Trials: see list990
Patent Applications: see list960
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:procainamide hydrochloride at DailyMed

Pharmacology for Ingredient: procainamide hydrochloride

Drug ClassAntiarrhythmic
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ascot
PROCAINAMIDE HYDROCHLORIDE
procainamide hydrochloride
CAPSULE;ORAL087542-001Jan 8, 1982DISCNNoNo► subscribe► subscribe
Ani Pharms Inc
PROCAINAMIDE HYDROCHLORIDE
procainamide hydrochloride
TABLET, EXTENDED RELEASE;ORAL088974-001Jul 22, 1985DISCNNoNo► subscribe► subscribe
Lederle
PROCAINAMIDE HYDROCHLORIDE
procainamide hydrochloride
CAPSULE;ORAL086943-001Approved Prior to Jan 1, 1982DISCNNoNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: procainamide hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
King Pharms
PROCANBID
procainamide hydrochloride
TABLET, EXTENDED RELEASE;ORAL020545-001Jan 31, 19965,656,296► subscribe
King Pharms
PROCANBID
procainamide hydrochloride
TABLET, EXTENDED RELEASE;ORAL020545-002Jan 31, 19965,656,296► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc